Inspire Medical Systems (NYSE:INSP) Shares Climb 4% – Time to Buy?

Inspire Medical Systems, Inc. (NYSE:INSP) was up 4% during mid-day trading on Monday. The company traded as high as $71.66 and last traded at $71.6680. 119,753 shares changed hands during mid-day trading, a decline of 89% from the average session volume of 1,067,725 shares. The stock had previously closed at $68.89.

Analyst Ratings Changes

A number of research analysts have issued reports on INSP shares. UBS Group began coverage on shares of Inspire Medical Systems in a research report on Tuesday, July 28th. They set a “sell” rating and a $39.00 target price on the stock. Mizuho set a $75.00 price target on shares of Inspire Medical Systems in a research report on Tuesday. Evercore set a $54.00 price target on Inspire Medical Systems in a research note on Tuesday, August 4th. Stifel Nicolaus increased their price target on Inspire Medical Systems from $75.00 to $80.00 and gave the stock a “buy” rating in a research report on Friday, September 11th. Finally, JPMorgan Chase & Co. increased their price target on Inspire Medical Systems from $54.00 to $60.00 and gave the stock a “neutral” rating in a research report on Tuesday, August 4th. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, twelve have assigned a Hold rating and four have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $67.88.

Inspire Medical Systems Stock Down 3.8%

The business’s 50 day moving average is $65.71 and its 200-day moving average is $54.43. The firm has a market capitalization of $1.99 billion, a P/E ratio of 31.49, a PEG ratio of 5.41 and a beta of 0.73.

Inspire Medical Systems (NYSE:INSP) last announced its quarterly earnings data on Monday, August 3rd. The company reported $0.14 EPS for the quarter, beating the consensus estimate of ($0.24) by $0.38. Inspire Medical Systems had a net margin of 15.03% and a return on equity of 8.64%. The business had revenue of $200.58 million during the quarter, compared to the consensus estimate of $194.72 million. During the same period in the previous year, the business earned $0.45 earnings per share. The company’s revenue was down 7.6% on a year-over-year basis. Inspire Medical Systems has set its FY 2026 guidance at 1.050-1.450 EPS. Research analysts forecast that Inspire Medical Systems, Inc. will post 1.24 EPS for the current fiscal year.

Insider Activity

In other news, insider Jason Kelly sold 963 shares of Inspire Medical Systems stock in a transaction on Friday, August 7th. The stock was sold at an average price of $59.55, for a total value of $57,346.65. Following the transaction, the insider owned 18,985 shares in the company, valued at approximately $1,130,556.75. This trade represents a 4.83% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 2.20% of the company’s stock.

Institutional Trading of Inspire Medical Systems

Several institutional investors and hedge funds have recently modified their holdings of the business. BlackRock Inc. acquired a new stake in shares of Inspire Medical Systems in the 2nd quarter valued at approximately $211,341,000. ADAR1 Capital Management LLC grew its holdings in shares of Inspire Medical Systems by 2,601.3% during the 1st quarter. ADAR1 Capital Management LLC now owns 405,197 shares of the company’s stock valued at $20,900,000 after purchasing an additional 390,197 shares during the last quarter. Assenagon Asset Management S.A. grew its holdings in shares of Inspire Medical Systems by 66.2% during the 2nd quarter. Assenagon Asset Management S.A. now owns 864,395 shares of the company’s stock valued at $38,561,000 after purchasing an additional 344,221 shares during the last quarter. Nantahala Capital Management LLC acquired a new position in Inspire Medical Systems during the 2nd quarter worth approximately $12,021,235. Finally, Bank of America Corp DE acquired a new position in Inspire Medical Systems during the 2nd quarter worth approximately $11,099,000. 94.91% of the stock is currently owned by institutional investors.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc is a medical technology company focused on developing and commercializing treatments for obstructive sleep apnea (OSA), a condition in which the upper airway repeatedly becomes blocked during sleep. The company’s primary product is the Inspire therapy system, an implantable device designed for certain adults with moderate to severe OSA who are unable to use or obtain consistent benefits from continuous positive airway pressure (CPAP) therapy.

The Inspire system uses an implantable pulse generator, a stimulation lead and a sensing lead.